Targeting the farnesoid X receptor in patients with cholestatic liver disease

Cynthia Levy

Targeting the farnesoid X receptor in patients with cholestatic liver disease

Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	263-265
Number of pages	3
Journal	Gastroenterology and Hepatology
Volume	12
Issue number	4
State	Published - Apr 2016

ASJC Scopus subject areas

Hepatology
Gastroenterology

Cite this

@article{2f959661b5af4269822e35325fbc7122,

title = "Targeting the farnesoid X receptor in patients with cholestatic liver disease",

author = "Cynthia Levy",

note = "Funding Information: Dr Levy is a principal investigator in studies using the FXR agonist obeticholic acid in PBC and PSC, and has received research grants from Intercept and Novartis. She is also a consultant and has participated in advisory boards for Intercept.",

year = "2016",

month = apr,

language = "English (US)",

volume = "12",

pages = "263--265",

journal = "Gastroenterology and Hepatology",

issn = "1554-7914",

publisher = "Gastro-Hep Communications, Inc.",

number = "4",

}

TY - JOUR

T1 - Targeting the farnesoid X receptor in patients with cholestatic liver disease

AU - Levy, Cynthia

N1 - Funding Information: Dr Levy is a principal investigator in studies using the FXR agonist obeticholic acid in PBC and PSC, and has received research grants from Intercept and Novartis. She is also a consultant and has participated in advisory boards for Intercept.

PY - 2016/4

Y1 - 2016/4

UR - http://www.scopus.com/inward/record.url?scp=84963726150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963726150&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:84963726150

VL - 12

SP - 263

EP - 265

JO - Gastroenterology and Hepatology

JF - Gastroenterology and Hepatology

SN - 1554-7914

IS - 4

ER -

Targeting the farnesoid X receptor in patients with cholestatic liver disease

ASJC Scopus subject areas

Other files and links

Cite this